OXR1 as A Potential Drug Target for Cancer Treatment (G55074)

Target Name: OXR1

NCBI ID: G55074

OXR1

OXR1 as A Potential Drug Target for Cancer Treatment

OXR1 (OXR1_HUMAN) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. OXR1 is a non-coding RNA molecule that plays a role in the regulation of gene expression.

The OXR1 gene has been shown to be involved in the regulation of various cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation. OXR1 has also been shown to be involved in the development and progression of various diseases, including cancer.

One of the key functions of OXR1 is its role in the regulation of apoptosis. Apoptosis is a natural process that helps the body eliminate damaged or dysfunctional cells. However, in diseases such as cancer, the process of apoptosis can become imbalanced and lead to the development of cancer cells. OXR1 has been shown to play a role in regulating the balance between pro-apoptotic and anti-apoptotic processes, which can help to control the development and progression of cancer.

Another function of OXR1 is its role in cell growth and development. OXR1 has been shown to play a role in the regulation of cell cycle progression, which is the process by which cells grow and divide. This function is important for the development and progression of cancer, as abnormal cell cycle progression can lead to the formation of cancer cells.

In addition to its role in apoptosis and cell growth, OXR1 has also been shown to be involved in the regulation of inflammation. OXR1 has been shown to play a role in the regulation of the immune response, which is important for the fight against cancer.

The potential implications of OXR1 as a drug target or biomarker are significant. OXR1 has been shown to play a role in the regulation of various cellular processes that are important for the development and progression of cancer. Identifying OXR1 as a potential drug target or biomarker provides a promising avenue for the development of new treatments for cancer and other diseases.

In conclusion, OXR1 is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. Its role in the regulation of apoptosis, cell growth, and inflammation makes it an attractive target for drug development. Further research is needed to fully understand the potential implications of OXR1 as a drug target or biomarker.

Protein Name: Oxidation Resistance 1

Functions: May be involved in protection from oxidative damage

The "OXR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OXR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets